A medical treatment system for determining administration of medications to a patient is disclosed. The system uses a plurality of sensors to perform a first set of physiologic measurements in a right side of the heart and a second set of physiologic measurements in a left side of the heart. The system also includes a receiver configured to receive measurement data regarding the first and second sets of physiologic measurements and output to a display device the received measurement data.

A patient-centered mobile communication system and method that includes a physician's main menu comprising a processor, a memory including computer program code, the memory and the computer program code configured to, with the processor, cause the system at least to perform a physician main menu with at least one selectable button (region) to view patient information regarding at least one patient for which a physician provide care, at least one selectable button (region) to view the identity of one or more physicians also providing care to said at least one patient, and at least one selectable button (region) to communicate with any one of the identified physicians.

A system for evaluating a kidney includes a processing device including an input module configured to acquire patient information, the patient information including at least one of demographic data, diagnostic data, physiological data and intervention data. The processing device also includes an evaluation module, which is configured to input patient class data to an initial kidney model, the initial kidney model configured to simulate a physiological response of a kidney and configured to simulate fluid and solute transport through one or more spatial locations of the kidney. The evaluation module is also configured to input patient data corresponding to an individual patient and calculating a model response, and adjust at least one parameter of the initial kidney model based on a comparison of the patient data and the model response to personalize the initial kidney model for the individual patient.

In some examples, a system is configured to determine a non-cerebral autoregulation status value of a patient using machine learning. In some examples, processing circuitry of the system is configured to determine, using a neural network algorithm that has been trained via machine learning training, an individualized adjustment value that is individualized for the patient, including inputting physiological data associated with the patient. The processing circuitry may determine a non-cerebral autoregulation status of the patient based on a cerebral autoregulation value of the patient based on the non-cerebral autoregulation status value of the patient and the adjustment value.

It is provided a method and devices for detecting kidney failure and dialysis of a subject wherein the epidermis is irreversibly electroporated without generating any heat and a negative pressure is applied forming micro-conduits in the epidermis from which the interstitial fluid can be extracted, analysed and filtered to produce for example a dialysate and returned to the subject.

Systems, devices, and methods are disclosed herein for monitoring physiological data of subjects seated on a toilet, including systems, devices, and methods for monitoring loads and forces on a toilet seat. In some embodiments, systems, devices, and methods disclosed herein include a set of sensors that can measure loads and forces present at coupling points between a toilet seat and a base or other components of a toilet.

An intravascular catheter for nerve activity ablation and/or sensing includes one or more needles advanced through supported guide tubes (needle guiding elements) which expand to contact the interior surface of the wall of the renal artery or other vessel of a human body allowing the needles to be advanced though the vessel wall into the extra-luminal tissue including the media, adventitia and periadvential space. The catheter also includes structures which provide radial and lateral support to the guide tubes so that the guide tubes open uniformly and maintain their position against the interior surface of the vessel wall as the sharpened needles are advanced to penetrate into the vessel wall. Electrodes at the distal ends of the guide tubes allow sensing of nerve activity before and after attempted renal denervation. In a combination embodiment ablative energy or fluid is delivered to ablate nerves outside of the media.

Systems and methods for controlled sympathectomy procedures for neuromodulation are disclosed. A system for controlled micro ablation procedures is disclosed. A guidewire including one or more sensors or electrodes for accessing and recording physiologic information from one or more anatomical sites within the parenchyma of an organ as part of a physiologic monitoring session, a diagnostic test, or a neuromodulation procedure is disclosed. A guidewire including one or more sensors and/or a means for energy delivery, for performing a neuromodulation procedure within a small vessel within a body is disclosed.

The present disclosure relates to systems and methods for determining the renal glomerular filtration rate or assessing the renal function in a patient in need thereof. The method includes administering a pyrazine compound of Formula I to a patient and monitoring the rate in which the kidneys of the patient eliminate the pyrazine from the systemic circulation of the patient. The pyrazine compound fluoresces when exposed to electromagnetic radiation which is detected using one or more sensors. The rate in which the fluorescence decreases in the patient is used to calculate the renal glomerular filtration rate in the patient.

A pharmaceutical composition for treating an influenza virus infectious disease, containing an anti-influenza virus agent as an active ingredient is provided. The anti-influenza virus agent is administered to a patient determined to be positive for the influenza virus infectious disease based on an intraoral image captured using an intraoral imaging apparatus.